HK105193A - Composition to prevent seasickness - Google Patents

Composition to prevent seasickness

Info

Publication number
HK105193A
HK105193A HK1051/93A HK105193A HK105193A HK 105193 A HK105193 A HK 105193A HK 1051/93 A HK1051/93 A HK 1051/93A HK 105193 A HK105193 A HK 105193A HK 105193 A HK105193 A HK 105193A
Authority
HK
Hong Kong
Prior art keywords
pct
sec
date
composition
pub
Prior art date
Application number
HK1051/93A
Other languages
English (en)
Inventor
Gyoergy Bodo
Knoll Jozsef
Eva Somfai
Sandor Virag
Ferenc Zak
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of HK105193A publication Critical patent/HK105193A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
HK1051/93A 1986-12-19 1993-10-07 Composition to prevent seasickness HK105193A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU865338A HU197510B (en) 1986-12-19 1986-12-19 Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
PCT/HU1987/000058 WO1988004552A1 (en) 1986-12-19 1987-12-18 Composition to prevent seasickness

Publications (1)

Publication Number Publication Date
HK105193A true HK105193A (en) 1993-10-15

Family

ID=10970131

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1051/93A HK105193A (en) 1986-12-19 1993-10-07 Composition to prevent seasickness

Country Status (26)

Country Link
US (1) US4925878A (fi)
EP (1) EP0294441B1 (fi)
JP (1) JP2534553B2 (fi)
AT (1) ATE82847T1 (fi)
BG (1) BG51918A1 (fi)
CY (1) CY1740A (fi)
CZ (1) CZ277831B6 (fi)
DD (1) DD264851A5 (fi)
DE (1) DE3782935T2 (fi)
DK (1) DK464788A (fi)
ES (1) ES2009228A6 (fi)
FI (1) FI883837A0 (fi)
GE (1) GEP19970949B (fi)
GR (1) GR871953B (fi)
HK (1) HK105193A (fi)
HU (1) HU197510B (fi)
IL (1) IL84786A (fi)
LT (1) LT4007B (fi)
LV (1) LV10185B (fi)
MD (1) MD408C2 (fi)
MX (1) MX9203088A (fi)
PT (1) PT86406B (fi)
RU (1) RU1825314C (fi)
SK (1) SK278500B6 (fi)
UA (1) UA19281A1 (fi)
WO (1) WO1988004552A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CS269271B1 (en) * 1988-05-30 1990-04-11 Hajicek Josef Method of selegiline's hydrochloride production
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (en) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
ES2149850T3 (es) * 1993-05-04 2000-11-16 Ceva Sante Animale Utilizacion de la selegilina en medicina veterinaria.
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
DE69520430T2 (de) 1994-06-03 2001-10-18 Jmde Trust Newton Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
US6033682A (en) * 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
WO1996024346A1 (en) * 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
DE69628415T3 (de) * 1995-03-02 2008-06-26 R.P. Scherer Technologies, Inc., Paradise Valley Arzneimittel enthaltend monoaminooxidase-b-hemmer
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
US6042533A (en) * 1998-07-24 2000-03-28 Kania; Bruce Apparatus and method for relieving motion sickness
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
US6443913B1 (en) 2000-03-07 2002-09-03 Bruce Kania Apparatus and method for relieving motion sickness
US6497649B2 (en) * 2001-01-21 2002-12-24 University Of Washington Alleviating motion, simulator, and virtual environmental sickness by presenting visual scene components matched to inner ear vestibular sensations
US7128705B2 (en) * 2002-11-26 2006-10-31 Artis Llc Motion-coupled visual environment for prevention or reduction of motion sickness and simulator/virtual environment sickness
AT16235U1 (de) * 2018-06-21 2019-04-15 Dr Reinhart Jarisch Kaugummi enthaltend Vitamin C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation
EP0564802B1 (de) 1992-04-10 1996-10-09 Schott Glaswerke Blei- und bariumfreies Kristallglas mit hoher Lichttransmission

Also Published As

Publication number Publication date
ATE82847T1 (de) 1992-12-15
LV10185B (en) 1995-04-20
MX9203088A (es) 1992-07-01
SK278500B6 (en) 1997-05-14
CZ277831B6 (en) 1993-06-16
JPH01501626A (ja) 1989-06-08
BG51918A1 (en) 1993-11-15
CY1740A (en) 1995-10-20
EP0294441A1 (en) 1988-12-14
LT4007B (en) 1996-07-25
PT86406B (pt) 1990-11-20
FI883837A (fi) 1988-08-18
UA19281A1 (uk) 1997-12-25
DD264851A5 (de) 1989-02-15
HUT45196A (en) 1988-06-28
DK464788D0 (da) 1988-08-18
CS8709491A1 (en) 1990-05-14
HU197510B (en) 1989-04-28
LV10185A (lv) 1994-10-20
US4925878A (en) 1990-05-15
JP2534553B2 (ja) 1996-09-18
MD408C2 (ro) 1996-07-31
IL84786A (en) 1991-08-16
GR871953B (en) 1988-04-19
RU1825314C (ru) 1993-06-30
EP0294441B1 (en) 1992-12-02
LTIP1849A (en) 1995-08-25
PT86406A (en) 1988-01-01
DE3782935D1 (de) 1993-01-14
GEP19970949B (en) 1997-03-31
DE3782935T2 (de) 1993-04-08
DK464788A (da) 1988-08-18
FI883837A0 (fi) 1988-08-18
ES2009228A6 (es) 1989-09-16
WO1988004552A1 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
CY1740A (en) Composition to prevent seasickness
NO308772B1 (no) Sublingual eller buckal farmasoytisk blanding inneholdende trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-c]pyrrol, samt anvendelse av forbindelsen for fremstilling av farmasoytisk blanding
CA2070388A1 (en) Antihypertensive compositions and use thereof
GR77915B (fi)
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
IL95740A0 (en) Pyrimidine-4,6-dicarboxylic acid diamides,processes for their preparation and the use thereof,and pharmaceuticals based on these compounds
GR3024686T3 (en) Novel guinolone and naphthyridone derivatives.
DE3273377D1 (en) Pyrimido quinoxalines and their salts, their preparation, their use as medicaments and compositions containing them
ES544417A0 (es) Procedimiento para preparar 8-alquiltio-2-piperazino-pirimido(5,4-d)pirimidinas.
ES519606A0 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
SE8802814D0 (sv) Beredningar for lokal anvendning
ES2071793T3 (es) Nuevos derivados de la pirrolidona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FI910159A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9a-hydroxi-3-oxo-4,24(25)-stigmastadien-26 -syraderivat.
ZA841418B (en) N-arylpiperazine derivatives
ZA858030B (en) Thiadiazole derivatives active on the central nervous system,process for their preparation and pharmaceutical compositions in which they are present
ES8606240A1 (es) Semiesteres pentanodioicos 3-sustituidos
GR3002417T3 (en) Derivatives of 8-phenylthiotetrahydroquinolines and their salts, their synthesis for use as medicaments and compositions containing them
DK30284D0 (da) Pyrrolidiner
ES489925A1 (es) Procedimiento para la preparacion de n,n'-difenil-monohidra-zida de acido 2-(3-metil-3-butenil)-malonico

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)